natgillin/translations-raw huggingface dataset:
The recommended daily dose of Tarceva is 100 mg taken at least one hour before or two hours after the ingestion of food, in combination with gemcitabine (see the summary of product characteristics of gemcitabine for the pancreatic cancer indication).In patients who do not develop rash within the first 4
Priporočeni dnevni odmerek zdravila Tarceva je 100 mg, ki ga vzamemo najmanj eno uro pred zaužitjem hrane ali dve uri po tem, v kombinaciji z gemcitabinom (glejte Povzetek glavnih značilnosti zdravila za gemcitabin, indikacija rak trebušne slinavke).
The recommended daily starting dose is 0.2 units/kg followed by individual dose adjustments.
Priporočeni začetni dnevni odmerek je 0,2 enoti/kg, nato je treba odmerek individualno prilagoditi.
The recommended dosage and duration of Pegasys for both HBeAg-positive and HBeAg-negative chronic hepatitis B is 180 micrograms once weekly for 48 weeks by subcutaneous administration in the abdomen or thigh.
Priporočeni odmerek in trajanje zdravljenja z zdravilom Pegasys tako za HBeAg pozitivni kot tudi za HBeAg negativni kronični hepatitis B je 180 mikrogramov enkrat na teden 48 tednov subkutano v trebuh ali stegno.
The recommended dosage for adults, adolescents and children aged 3 years of age and older is a total of 2 injections of 0.5 ml each:
Priporočeni odmerek za odrasle, mladostnike in otroke, stare 3 leta ali več, je skupaj 2 injekciji s po 0,5 ml:
The recommended dosage for babies and children aged 2 months to < 3 years is a total of 2 injections of 0.25 ml each:
Priporočeni odmerek za dojenčke in otroke, stare 2 meseca do < 3 leta, je skupaj 2 injekciji s po 0,25 ml:
The recommended dosage for cholic acid in the treatment of inborn errors of primary bile acid synthesis is 10-15 mg/kg per day, either as a single daily dose or in divided doses, for both adult and paediatric patients.
Priporočeni odmerek holne kisline pri zdravljenju prirojenih napak v sintezi primarnih žolčnih kislin je 10–15 mg/kg na dan, v enkratnem dnevnem odmerku ali v razdeljenih odmerkih, kar velja za odrasle in pediatrične bolnike.
The recommended dosage is 1 ml of the veterinary medicinal product per infected ear once a day for five consecutive days.
Priporočen odmerek je 1 ml zdravila za uporabo v veterinarski medicini na uho enkrat na dan v petih zaporednih dneh.
The recommended dosage is 1.52 µg of hydrocortisone aceponate/cm2 of affected skin per day.
Priporočen odmerek je 1,52 µg hidrokortizon aceponata/cm2 prizadete kože na dan.
The recommended dosage is 1.52 µg of hydrocortisone aceponate/cm2 of affected skin per day.
Za zdravljenje prizadetega dela kože se priporoča odmerek z 1,52 µg hidrokortizon-aceponata/cm2 na dan.
The recommended dosage is 100 I.U. daily or 50 I.U. twice daily for 2 to 4 weeks, administered subcutaneously or intramuscularly.
Priporočeni odmerek je 100 IE na dan ali 50 IE dvakrat na dan, 2 do 4 tedne, dan subkutano ali intramuskularno.
The recommended dosage is 200 mg once daily for 6 days.
Priporočeni odmerek je 200 mg enkrat dnevno 6 dni.
The recommended dosage is 400 mg (one tablet) twice daily.
Priporočeni odmerek je 400 mg (ena tableta) dvakrat na dan.
The recommended dosage is approximately 47 micrograms depreotide (one vial) labelled with 555-740 MBq of technetium-99m.
Priporočeno odmerjanje je približno 47 mikrogramov depreotida (ena viala) označenega z 555-740 Mbq tehnecija-99m.
The recommended dosage is as follows:
Priporočen odmerek je:
The recommended dosage is in the range 5 to 10 million IU administered subcutaneously three times a week (every other day) for a period of 4 to 6 months.
Priporočeni odmerek je v razponu od 5 do 10 milijonov i.e., injiciran subkutano trikrat na teden (vsak drugi dan) v obdobju 4 do 6 mesecev.
The recommended dosage is one tablet (150 mg lamivudine/300 mg raltegravir) twice daily.
Priporočeni odmerek je ena tableta (150 mg lamivudina/300 mg raltegravirja) dvakrat na dan.
The recommended dosage is one vial (approximately 47 micrograms of depreotide) labelled with 555-740 MBq of technetium-99m.
Priporočeno odmerjanje je ena viala (približno 47 mikrogramov depreotida) označena s 555–740 MBq tehnecija-99m .
The recommended dosage of HETLIOZ is 20 mg (1 capsule) per day taken one hour before bedtime, at the same time every night.
Priporočeni odmerek zdravila HETLIOZ je 20 mg (1 kapsula) na dan, ki se vzame eno uro pred spanjem, vsak večer ob istem času.
The recommended dosage of Kaletra is 230/57.5 mg/m2 twice daily taken with food, up to a maximum dose of 400/100 mg twice daily.
Priporočeni odmerek zdravila Kaletra je 230/57,5 mg/m2 dvakrat na dan s hrano, do največjega odmerka 400/100 mg dvakrat na dan.
The recommended dosage of Lamivudine Teva is 100 mg once daily.
Priporočeni odmerek zdravila Lamivudin Teva je 100 mg enkrat dnevno.
The recommended dosage of MabThera for induction of remission therapy of granulomatosis with polyangiitis and microscopic polyangiitis is 375 mg/m2 body surface area, administered as an intravenous infusion once weekly for 4 weeks (four infusions in total).
Priporočeno odmerjanje zdravila MabThera za indukcijo remisije pri zdravljenju granulomatoze s poliangiitisom in mikroskopskega poliangiitisa je 375 mg/m2 telesne površine v intravenski infuziji 1- krat na teden 4 tedne (skupaj štiri infuzije).
The recommended dosage of MabThera in combination with chemotherapy for previously untreated and relapsed/refractory patients is 375 mg/m2 body surface area administered on day 0 of the first treatment cycle followed by 500 mg/m2 body surface area administered on day 1 of each subsequent cycle for 6 cycles in total.
Priporočeni odmerek zdravila MabThera v kombinaciji s kemoterapijo pri bolnikih, ki predhodno še niso bili zdravljeni oziroma se na prejšnje zdravljenje niso odzvali ali pa se je bolezen pri njih ponovila, je 375 mg/m2 telesne površine, ki ga damo na dan 0 prvega cikla zdravljenja, v naslednjih ciklih zdravljenja pa dajemo 1. dan 500 mg/m2 telesne površine, skupaj 6 ciklov.
The recommended dosage of MabThera is 1000 mg by intravenous infusion followed by a second 1000 mg intravenous infusion two weeks later.
Priporočeni odmerek zdravila MabThera je 1.000 mg z intravensko infuzijo, čemur sledi druga intravenska infuzija 1.000 mg 2 tedna pozneje.
The recommended dosage of Myozyme in children and adolescents is the same as in adults.
Priporočen odmerek zdravila Myozyme pri otrocih in mladostnikih je enak kot pri odraslih.
The recommended dosage of Norvir in children is 350 mg/m² by mouth twice daily and should not exceed 600 mg twice daily.
Priporočeno odmerjanje zdravila Norvir pri otrocih je 350 mg/m2 peroralno dvakrat na dan in ne sme preseči 600 mg dvakrat na dan.
The recommended dosage of Norvir powder for suspension in children is 350 mg/m² by mouth twice daily and should not exceed 600 mg twice daily.
Priporočeno odmerjanje zdravila Norvir prašek za peroralno suspenzijo pri otrocih je 350 mg/m2 peroralno dvakrat na dan in ne sme preseči 600 mg dvakrat na dan.
The recommended dosage of Norvir solution in children is 350 mg/m² by mouth twice daily and should not exceed 600 mg twice daily.
Priporočeno odmerjanje raztopine Norvir pri otrocih je 350 mg/m2 peroralno dvakrat na dan in ne sme preseči 600 mg dvakrat na dan.
The recommended dosage of Norvir solution is 600 mg (7.5 ml) twice daily by mouth.
Priporočeno odmerjanje raztopine Norvir je 600 mg (7,5 ml) peroralno dvakrat na dan.
The recommended dosage of Oxyglobin is 30 ml/kg of body weight administered intravenously at a rate up to 10 ml/kg/h.
Priporočeni odmerek Oxyglobina je 30 ml/kg telesne mase, dan intravensko s hitrostjo do 10 ml/kg/uro.
The recommended dosage of Oxyglobin is 30 ml/kg of body weight administered intravenously at a rate up to 10 ml/kg/hr.
Priporočeni odmerek Oxyglobina je 30 ml/kg telesne mase, dan intravensko s hitrostjo do 10 ml/kg/uro.
The recommended dosage of Plegridy is 125 micrograms injected subcutaneously every 2 weeks (14 days).
Priporočeni odmerek zdravila Plegridy je 125 mikrogramov, injiciranih subkutano vsaka 2 tedna (14 dni).
The recommended dosage regimen must be followed but not exceeded (see section 4.10).
Priporočeni režim odmerjanja je treba upoštevati, a ne preseči (glejte poglavje 4.10).
The recommended dosage regimen must be followed but not exceeded.
Priporočeni režim odmerjanja je treba upoštevati, vendar se ne sme preseči.
The recommended dosage regimen should be followed (see section 4.10 for information regarding overdose).
Upoštevajte priporočeno tabelo odmerjanja (za informacije o prekomernem odmerjanju glejte poglavje 4.10).
The recommended dosage regimens based on age for paediatric patients with cSSTI are shown below.
Spodaj so navedeni priporočeni režimi odmerjanja glede na starost bolnikov z zapletenimi okužbami kože in mehkih tkiv.
The recommended dosages for patients naïve to phenylbutyric acid and for patients switching from sodium phenylbutyrate to RAVICTI are different.
Priporočeni odmerki za bolnike, ki še niso prejemali fenilbutirične kisline, in za bolnike, ki so prešli z natrijevega fenilbutirata na zdravilo RAVICTI, se razlikujejo.
The recommended dose adjustments do not apply to the haemodialysis indication.
Prilagoditve priporočenega odmerjanja ne veljajo, če je zdravilo indicirano pri hemodializi.
The recommended dose and duration of ribavirin depends on patient’s weight and on the medicinal product that is used in combination.
Priporočeno odmerjanje in trajanje zdravljenja z ribavirinom je odvisno od bolnikove telesne mase in od zdravila uporabljenega pri kombiniranem zdravljenju.
The recommended dose and duration of Ribavirin Teva depends on how much the patient weighs and the medicines that are used in combination.
Priporočeni odmerek in trajanje zdravljenja z zdravilom Ribavirin Teva sta odvisna od bolnikove telesne mase in zdravil, uporabljenih v kombinaciji.
The recommended dose and duration of Ribavirin Teva depends on patient’s weight and on the medicinal product that is used in combination.
Priporočeni odmerek in trajanje zdravljenja z zdravilom Ribavirin Teva sta odvisna od bolnikove telesne mase in zdravil, ki so uporabljena v kombinaciji.
The recommended dose and regimen of ONIVYDE is 80 mg/m2 intravenously over 90 minutes, followed by
Priporočeni odmerek in režim odmerjanja zdravila ONIVYDE je 80 mg/m2 intravensko 90 minut, čemur sledi
The recommended dose and schedule is 1 ± 0.2 x 107 cells/kg given as an intravenous infusion at a time interval of 21-49 days from transplantation, in the absence of spontaneous immune reconstitution and/or development of graft-versus-host disease (GvHD).
Priporočeni odmerek in režim dajanja je 1 ± 0,2 x 107 celic/kg v obliki infuzije v časovnem intervalu 21 do 49 dni od presaditve, v odsotnosti spontane imunske reaktivacije in/ali razvoja reakcije presadka proti gostitelju (GvHD-graft-versus-host disease).
The recommended dose and schedule is 300 mg on day 1 followed 1 week later by 1,000 mg on day 8 (cycle 1), followed by 1,000 mg on day 1 of subsequent cycles, for a minimum of 3 cycles, until best response or a maximum of 12 cycles (every 28 days).
Priporočeni odmerki in časovni razpored so 300 mg 1. dan, nato čez 1 teden 1.000 mg 8. dan (1. ciklus), potem 1.000 mg 1. dan nadaljnjih ciklusov (vsaj 3 cikluse), do najboljšega odziva oziroma največ 12 ciklusov (vsakih 28 dni).
The recommended dose and schedule of administration is:
Priporočeni odmerek in razpored uporabe busulfana:
The recommended dose and schedule of administration is: fludarabine administered as a single daily one-hour infusion at 30 mg/m² for 5 consecutive days or 40 mg/m² for 4 consecutive days.
Priporočeni odmerek in razpored uporabe: fludarabin se daje kot 1-urna infuzija enkrat na dan v odmerku 30 mg/m², 5 dni zaporedoma, ali v odmerku 40 mg/m², 4 dni zaporedoma.
The recommended dose depends on the patient’s body weight and depends on the condition to be treated and whether Herceptin is given weekly or three-weekly.
Priporočeni odmerek je odvisen od telesne mase bolnika, vrste zdravljene bolezni, in od tega, ali se zdravilo Herceptin daje tedensko ali vsake tri tedne.
The recommended dose for
Priporočeni odmerek
The recommended dose for adults is 1 sachet three times a day, with a schedule of 1 sachet every 8 hours.
Priporočeni odmerek za odrasle je 1 vrečka trikrat na dan, pri čemer je treba vzeti 1 vrečko na vsakih 8 ur.
The recommended dose for adults is 100 mg twice daily for 24 weeks.
Priporočeni odmerek za odrasle je 100 mg dvakrat na dan, ki se jemlje 24 tednov.
The recommended dose for adults is 100 mg.
Priporočeni odmerek za odrasle je 100 mg.
The recommended dose for adults is 300 mg given once every 4 weeks.
Priporočeni odmerek za odrasle je 300 mg na vsake štiri tedne.
The recommended dose for adults is 75 mg three times per 24 hours for 28 days.
Priporočeni odmerek za odrasle je 75 mg trikrat na 24 ur, 28 dni.
The recommended dose for adults with primary disease is either 140 mg every two weeks or 420 mg (the contents of three pre-filled syringes) once a month.
Priporočeni odmerek pri odraslih s primarno boleznijo je 140 mg vsaka dva tedna ali 420 mg (kar je vsebina treh napolnjenih injekcijskih brizg) enkrat na mesec.
The recommended dose for an adult or an adolescent 12 years and above is:
Priporočeni odmerek za odraslega ali mladostnika, starega 12 let ali več je:
The recommended dose for ASA was 75 to 100 mg/day.
Priporočeni odmerek acetilsalicilne kisline je bil od 75 do 100 mg na dan.
The recommended dose for ASA was 75 to 100 mg/day.
Priporočeni odmerek ASA je bil od 75 do 100 mg na dan.
The recommended dose for cats is 25 mg indoxacarb/kg body weight, equivalent to 0.128 ml/kg body weight.
Priporočeni odmerek je 25 mg indoksakarba/kg telesne teže, kar odgovarja 0,128 ml/kg telesne teže.
The recommended dose for children (age 2 to 12 years) is 375 mg/m2 Aptivus co-administered with 150 mg/m2 ritonavir, twice daily.
Priporočeni odmerek za otroke (stare 2 do 12 let) je 375 mg/m2 Aptivus 2-krat na dan hkrati s 150 mg/m2 ritonavirja.
The recommended dose for children 3 months to 12 years of age is 15 mg/kg given twice daily (not to exceed 1 g/day).
Priporočeni odmerek za otroke, stare od 3 mesece do 12 let, je 15 mg/kg dvakrat na dan (odmerek ne sme biti večji od 1 g na dan).
The recommended dose for children aged 1 month to 18 years is the same mg/kg dose as for adults i.e.
Priporočeni odmerek pri otrocih, starih od 1 meseca do 18 let, je enak odmerku na osnovi mg/kg kot pri odraslih, tj.
The recommended dose for children and adolescents is 0.2 ml Fluenz, administered as 0.1 ml in each nostril.
Priporočeni odmerek je tako za otroke kot za mladostnike 0,2 ml cepiva Fluenz, danega po 0,1 ml v vsako nosnico.
The recommended dose for children and adolescents is 0.2 ml Pandemic influenza vaccine H5N1 MedImmune, administered as 0.1 ml in each nostril.
Priporočeni odmerek za otroke in mladostnike je 0,2 ml Cepiva proti pandemski gripi H5N1 MedImmune, po 0,1 ml v vsako nosnico.
The recommended dose for children from birth up to the age of 15 years is 0.5 ml of the lower strength (10 micrograms/ml) at each injection.
Priporočeni odmerek za otroke, stare do 15 let, je 0,5 ml zdravila nižje jakosti (10 mikrogramov/ml) z vsako injekcijo.
The recommended dose for dogs is 15 mg indoxacarb and 48 mg permethrin per kg bodyweight, equivalent to 0.1 ml/kg bodyweight.
Priporočeni odmerek za pse je 15 mg indoksakarba in 48 mg permetrina na kg telesne mase, kar ustreza 0,1 ml/kg telesne mase .
The recommended dose for dogs is 15 mg indoxacarb/kg body weight, equivalent to 0.077 ml/kg body weight.
Priporočeni odmerek je 15 mg indoksakarba/kg telesne teže, kar ustreza 0,077 ml/kg telesne teže.
The recommended dose for DUAVIVE is 0.45 mg conjugated oestrogens (CE) and 20 mg bazedoxifene taken as a single oral tablet, once daily.
Priporočeni odmerek zdravila DUAVIVE je 0,45 mg konjugiranih estrogenov (CE – conjugated oestrogens) in 20 mg bazedoksifena v obliki ene peroralne tablete enkrat na dan.
The recommended dose for each infusion is 3 mg per kilogram body weight.
Priporočeni odmerek na posamezno infuzijo je 3 mg na kilogram telesne mase.
The recommended dose for Eylea is 2 mg aflibercept equivalent to 50 microlitres.
Priporočeni odmerek zdravila Eylea je 2 mg aflibercepta, kar ustreza 50 mikrolitrom raztopine.
The recommended dose for Herceptin solution for injection in administration system is 600 mg.
Priporočeni odmerek zdravila Herceptin raztopina za injiciranje v aplikacijskem sistemu je 600 mg.
The recommended dose for Herceptin subcutaneous formulation in administration system is 600 mg irrespective of the patient’s body weight.
Priporočeni odmerek zdravila Herceptin v subkutani obliki v aplikacijskem sistemu je 600 mg ne glede na bolnikovo telesno maso.
The recommended dose for Herceptin subcutaneous formulation is 600 mg irrespective of the patient’s body weight.
Priporočeni odmerek zdravila Herceptin v subkutani obliki je 600 mg ne glede na bolnikovo telesno maso.
The recommended dose for HIV-1 infected paediatric patients aged 6 to < 12 years weighing
Priporočeni odmerek za pediatrične bolnike, okužene s HIV-1, stare 6 do < 12 let, s telesno maso
The recommended dose for Lucentis is 0.5 mg given as a single intravitreal injection.
Priporočeni odmerek zdravila Lucentis je 0,5 mg, kar bolnik prejme z eno intravitrealno injekcijo.
The recommended dose for patients aged 12 years and over is two tablets twice a day (12 hours apart, a total of four tablets [800 mg of lumacaftor/500 mg of ivacaftor] per day).
Priporočeni odmerek za bolnike, stare 12 let ali več, je dve tableti dvakrat na dan (s presledkom 12 ur, skupaj štiri tablete [800 mg lumakaftorja/500 mg ivakaftorja] na dan).
The recommended dose for patients receiving supportive care for advanced illness is 8 mg methylnaltrexone bromide (0.4 mL of solution) for patients weighing 38-61 kg or 12 mg (0.6 mL of solution) for patients weighing 62-114 kg.
Priporočeni odmerek za bolnike, ki prejemajo podporno nego za napredovalo bolezen, je 8 mg metilnaltreksonijevega bromida (0,4 ml raztopine) za bolnike, ki tehtajo 38–61 kg, ali 12 mg (0,6 ml raztopine) za bolnike, ki tehtajo 62–114 kg.
The recommended dose for patients receiving supportive care in advanced illness is 8 mg methylnaltrexone bromide (0.4 mL of solution) for patients weighing 38-61 kg or 12 mg (0.6 mL of solution) for patients weighing 62-114 kg.
Priporočeni odmerek za bolnike, ki prejemajo podporno nego za napredovalo bolezen, je 8 mg metilnaltreksonijevega bromida (0,4 ml raztopine) za bolnike, ki tehtajo 38–61 kg, ali 12 mg (0,6 ml raztopine) za bolnike, ki tehtajo 62–114 kg.
The recommended dose for patients with long-term pain (except patients receiving supportive care for advanced illness) is 12 mg methylnalrexone bromide (0.6 mL of solution) given as an injection under the skin , as needed, but at least given 4 times a week and up to once a day (7 times a week).
Priporočeni odmerek za bolnike z dolgotrajno bolečino (razen za bolnike, ki prejemajo podporno nego zaradi napredovale bolezni), je 12 mg metilnaltreksonijevega bromida (0,6 ml raztopine), dane v obliki podkožne injekcije po potrebi, vendar vsaj 4-krat na teden in največ enkrat na dan (7-krat na teden).
The recommended dose for patients with long-term pain (except patients receiving supportive care for advanced illness) is 12 mg methylnalrexone bromide (0.6 mL of solution) given as an injection under the skin, as needed, but at least given 4-times a week and up to once a day (7 times a week).
Priporočeni odmerek za bolnike z dolgotrajno bolečino (razen za bolnike, ki prejemajo podporno nego zaradi napredovale bolezni), je 12 mg metilnaltreksonijevega bromida (0,6 ml raztopine), dane v obliki podkožne injekcije po potrebi, vendar vsaj 4-krat na teden in največ enkrat na dan (7-krat na teden).
The recommended dose for Pegasys is 180 micrograms once weekly by subcutaneous administration in the abdomen or thigh given in combination with oral ribavirin or as monotherapy.
Priporočeni odmerek zdravila Pegasys je 180 mikrogramov enkrat na teden subkutano v trebuh ali stegno, ki je dan v kombinaciji s peroralnim ribavirinom ali kot monoterapija.
The recommended dose for prevention of skeletal events in patients with breast cancer and bone metastases is 6 mg intravenous injection given every 3-4 weeks.
Priporočeni odmerek za preprečevanje z okostjem povezanih dogodkov pri bolnikih z rakom dojke in metastazami v kosteh je 6 mg v obliki intravenske injekcije in ga damo vsake 3 do 4 tedne.
The recommended dose for prevention of skeletal events in patients with breast cancer and bone metastases is 6 mg intravenously given every 3-4 weeks.
Priporočeni odmerek za preprečevanje dogodkov, povezanih z okostjem pri bolnikih z rakom dojke in metastazami v kosteh je 6 mg intravensko danih vsake 3 do 4 tedne.
The recommended dose for prevention of skeletal events in patients with breast cancer and bone metastases is 6 mg intravenously given every 3-4 weeks.
Priporočeni odmerek za preprečevanje dogodkov, povezanih z okostjem pri bolnikih z rakom dojke in metastazami v kosteh je 6 mg intravensko, danih vsake 3 do 4 tedne.
The recommended dose for the initial treatment of acute DVT or PE is 15 mg twice daily for the first three weeks followed by 20 mg once daily for the continued treatment and prevention of recurrent DVT and PE, as indicated in the table below.
Priporočeni odmerek za začetno zdravljenje akutne GVT ali PE je prve tri tedne 15 mg dvakrat na dan, nato pa 20 mg enkrat na dan kot nadaljevanje zdravljenja in preprečevanje ponovne GVT in PE, kot je navedeno v spodnji preglednici.
The recommended dose for the treatment of adolescent patients (12 years of age and above) with Niemann-Pick type C disease is 200 mg three times a day.
Priporočeni odmerek za zdravljenje mladostnikov (starih 12 let in več) z Niemann-Pickovo boleznijo tipa C je 200 mg trikrat dnevno.
The recommended dose for the treatment of CLL, either as a single agent or in combination, is 420 mg (three capsules) once daily (see section 5.1 for details of the combination regimen).
Priporočeni odmerek za zdravljenje KLL, samostojno ali v kombinaciji, je 420 mg (tri kapsule) enkrat na dan (za podrobne informacije o odmerjanju v kombinaciji glejte poglavje 5.1).
The recommended dose for the treatment of MCL is 560 mg (four capsules) once daily.
Priporočeni odmerek za zdravljenje MCL je 560 mg (štiri kapsule) enkrat na dan.
The recommended dose for treatment of bleeding episodes and for the prevention of bleeding in patients undergoing surgery or invasive procedures is 90 µg (range 80 – 120 µg) per kg body weight at intervals of two hours (1.5 – 2.5 hours).
Priporočeni odmerek za zdravljenje krvavitev in za preprečevanje krvavitev pri bolnikih, ki so prestali operacije ali invazivne postopke, je 90 µg (razpon od 80 do 120 µg) na kg telesne mase v dveurnih presledkih (od 1,5 do 2,5 ure).
The recommended dose for you or your child will depend on your or your child’s age and weight.
Priporočeni odmerek za vas ali vašega otroka bo odvisen od starosti in telesne mase.
The recommended dose in adults is 6 g per day divided in 2 doses of 3 g per day.
Priporočeni odmerek pri odraslih je 6 g na dan, razdeljenih na 2 odmerka po 3 g na dan.
The recommended dose in haematological diseases ranges from 125 mg/m2/day (5 mg/kg/day) to 250 mg/m2/day (10 mg/kg/day) divided in one or two daily infusions, administered from 1 up to 3 consecutive days before allogeneic HPCT depending on the combination with other chemotherapeutic medicinal products, without exceeding the total maximum cumulative dose of 375 mg/m2 (15 mg/kg), during the time of the entire conditioning treatment.
Priporočeni odmerek pri hematoloških boleznih je od 125 mg/m2 na dan (5 mg/kg/dan) do 250 mg/m2 na dan (10 mg/kg/dan), razdeljen na eno ali dve infuziji na dan, in se daje 1 do 3 zaporedne dni pred alogensko PKMC, odvisno od kombinacije z drugimi kemoterapevtiki, ne da bi se presegel skupni največji kumulativni odmerek 375 mg/m2 (15 mg/kg) v času celotnega pripravljalnega zdravljenja.